Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Idiopathic Nephrotic Syndrome
NCT03501459Phase 3Recruiting
- Sponsor
- National University Health System
- Start
- Jun 2008
- Primary completion
- Dec 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in nephrotic syndrome, sponsored by National University Health System. Started Jun 2008; status: recruiting.
02
Drugs
rituximab
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT03501459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03501459.